ITI Pharma and Healthcare Fund Direct Growth

ITI Pharma and Healthcare Fund Direct Growth

Equity

ITI Mutual Fund

Sector - Healthcare

Get the latest NAV of ITI Pharma and Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹16.94

▲0.9%1D

NAV as on 13 May 2025

15.93%/per year

Since Inception

Absolute Gain%

▲▼

152 people have invested ₹ 5L in ITI Pharma and Healthcare Fund Direct Growth in the last three months

ITI Pharma and Healthcare Fund Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (13-May-25)

The fund has outperformed the benchmark (Nifty 500) over 1Y, 3Y, but underperformed over 5Y.

Period
This Fund
Nifty 500
Category Avg
1 Month
2.8%
8.47%
3.21%
3 Months
1.79%
7.67%
1.68%
6 Months
-5.25%
0.81%
-3.86%
1 Year
19.17%
9.98%
18.38%
3 Years
24.24%
18.69%
22.56%

Peer comparison

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
Inception Returns
ITI Pharma and Healthcare Fund
-
219Cr
0.47%
19.17%
24.24%
15.93%
SBI Healthcare Opportunities Fund Direct Growth
1/8
3,671Cr
0.9%
22.04%
28.99%
18.15%
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
3/8
4,915Cr
1.11%
23.79%
28.39%
22.38%
DSP Healthcare Fund Direct Growth
4/8
2,912Cr
0.63%
13.56%
24.86%
24.03%
See all

ITI Pharma and Healthcare Fund Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

ITI Pharma and Healthcare Fund Asset Allocation

See fund asset allocation details as on (15-Apr-25)

Fund Distribution

as on (15-Apr-25)

Equity 97.5%

Debt & Cash 2.5%

Mid cap
33.8%
Small cap
31.6%
Large cap
29.2%
Large Cap allocation has gone down from 30% to 29.2%
Large Cap allocation has gone down from 30% to 29.2%
Small Cap allocation has gone up from 30.5% to 31.6%
Small Cap allocation has gone up from 30.5% to 31.6%
Mid Cap allocation has gone down from 34.5% to 33.8%
Mid Cap allocation has gone down from 34.5% to 33.8%
Cash allocation has gone down from 2.1% to 2%
Cash allocation has gone down from 2.1% to 2%

ITI Pharma and Healthcare Fund Sector Allocation

See fund sector allocation details as on (15-Apr-25)

Sector Allocation

Equity 97.5%

Debt & Cash 2.5%

Health
97.2%
Basic Materials
2.8%

Top 3 Sectors in March were Health, Basic Materials & Industrial

Mar'25

Health

95%

Basic Materials

4%

Industrial

1%

Feb'25

Health

96%

Basic Materials

3%

Industrial

1%

ITI Pharma and Healthcare Fund Holdings Details

as on (30-Apr-25)

Equity

Top Stocks bought last month
Abbott India Ltd's allocation increased from 1.08% to 2.43%
Abbott India Ltd's allocation increased from 1.08% to 2.43%
Max Healthcare Institute Ltd Ordinary Shares's allocation increased from 4.23% to 5.07%
Max Healthcare Institute Ltd Ordinary Shares's allocation increased from 4.23% to 5.07%
Supriya Lifescience Ltd's allocation increased from 1.19% to 1.71%
Supriya Lifescience Ltd's allocation increased from 1.19% to 1.71%
Top Stocks sold last month
Lupin Ltd's allocation decreased from 6.26 % to 5.78 %
Lupin Ltd's allocation decreased from 6.26 % to 5.78 %
Suven Pharmaceuticals Ltd's allocation decreased from 6.06 % to 5.39 %
Suven Pharmaceuticals Ltd's allocation decreased from 6.06 % to 5.39 %
Aurobindo Pharma Ltd's allocation decreased from 4.65 % to 3.61 %
Aurobindo Pharma Ltd's allocation decreased from 4.65 % to 3.61 %

ITI Pharma and Healthcare Fund Direct Growth Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio0.47%
Benchmark
Nifty Healthcare TR INR
AUM₹219 Cr
Inception Date11 November, 2021
Min Lumpsum/SIP₹5000/₹500
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
61.96%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

About ITI Pharma and Healthcare Fund

ITI Pharma and Healthcare Fund Direct Growth is an equity fund. This fund was started on 11 November, 2021. The fund is managed by . The fund could potentially beat inflation in the long-run.

Key Parameters

  1. ITI Pharma and Healthcare Fund Direct Growth has ₹219 Cr worth of assets under management (AUM) as on Mar 2025 and is less than category average.
  2. The fund has an expense ratio 0.5.

Returns

ITI Pharma and Healthcare Fund Direct Growth has given a CAGR return of 15.93% since inception. Over the last 1 and 3 years the fund has given a CAGR return of 19.17% and 24.24% respectively.

Holdings

ITI Pharma and Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials, Industrial. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Lupin Ltd, Suven Pharmaceuticals Ltd, Apollo Hospitals Enterprise Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of ITI Pharma and Healthcare Fund Direct Growth

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 500.00. ITI Pharma and Healthcare Fund Direct Growth has no lock in period.

Learn more about ITI Mutual Fund
Parameters
Mar'25
Feb'25
Jan'25
AUM
₹ 213.8 Cr
₹ 200.8 Cr
₹ 216.5 Cr
  • AUM of the fund stands at 213.8 Cr as of Mar'25
  • AUM increased by 12.9 Cr between Mar'25 and Feb'25

Compare ITI Pharma and Healthcare Fund

ITI Pharma and Healthcare Fund

VS

Nippon India Pharma Fund Direct Growth

Frequently Asked Questions for ITI Pharma and Healthcare Fund Direct Growth

What is the current NAV of ITI Pharma and Healthcare Fund Direct Growth?

The current NAV of ITI Pharma and Healthcare Fund Direct Growth is ₹16.94 as on 13-May-2025.

What are the average returns of ITI Pharma and Healthcare Fund Direct Growth?

Existing (Absolute + CAGR) as on 13-May-2025.
ITI Pharma and Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
2.8%
2.8%
6 Month Returns
-5.25%
-5.25%
1 Year Returns
19.17%
19.17%
3 Years Returns
91.77%
24.24%

How do I invest in ITI Pharma and Healthcare Fund Direct Growth?

With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.

What is the expense ratio of ITI Pharma and Healthcare Fund Direct Growth?

0.47% as on April 2025

What is net assets under management (AUM) of ITI Pharma and Healthcare Fund Direct Growth?

₹219 Cr as on April 2025

What are the top 5 holdings of ITI Pharma and Healthcare Fund Direct Growth?

Sun Pharmaceuticals Industries Ltd(16.22%), Divi's Laboratories Ltd(5.96%), Lupin Ltd(5.78%), Suven Pharmaceuticals Ltd(5.39%), Apollo Hospitals Enterprise Ltd(5.16%) as on April 2025

What are the top 3 sectors that this ITI Pharma and Healthcare Fund Direct Growth has invested in?

Health(93.27%), Basic Materials(3.23%), Industrial(0.98%) as on April 2025

What is the alpha of ITI Pharma and Healthcare Fund Direct Growth?

The alpha ratio for the ITI Pharma and Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
ITI Pharma and Healthcare Fund Direct Growth
1.04
2.45
-
As on April 2025
The alpha for ITI Pharma and Healthcare Fund Direct Growth is calculated against Nifty Healthcare TR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.

What is the beta of ITI Pharma and Healthcare Fund Direct Growth??

The Beta ratio for the ITI Pharma and Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
ITI Pharma and Healthcare Fund Direct Growth
0.96
0.9
-
As on April 2025
The Beta for ITI Pharma and Healthcare Fund Direct Growth is calculated with Nifty Healthcare TR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.

What is the sharpe ratio of ITI Pharma and Healthcare Fund Direct Growth?

The sharpe ratio for the ITI Pharma and Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
ITI Pharma and Healthcare Fund Direct Growth
0.61
0.87
-
As on April 2025
The sharpe ratio for ITI Pharma and Healthcare Fund Direct Growth is calculated with Nifty Healthcare TR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.

What is the standard deviation of ITI Pharma and Healthcare Fund Direct Growth?

The standard deviation for the ITI Pharma and Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
ITI Pharma and Healthcare Fund Direct Growth
20.52
16.38
-
As on April 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.

What is the Sortino ratio of ITI Pharma and Healthcare Fund Direct Growth?

Sortino ratio is 1.44 as on April 2025. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.

What is the information ratio of ITI Pharma and Healthcare Fund Direct Growth?

Information ratio is 0.36 as on April 2025. It tells the consistency of the fund in generating superior risk-adjusted performance

What is the exit load of ITI Pharma and Healthcare Fund Direct Growth?

The Exit load of ITI Pharma and Healthcare Fund Direct Growth is 1%